Deosen Biochemical (Ordos) Ltd. – Trademark Portfolio
Entity Type: 99
Deosen Biochemical (Ordos) Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include DEOSEN, ZIBOGEL, and ZIBOZAN.
200 Meter West Across,
The Road Between Jingsanlu And Weiwulu, Sanshangliang Industrial Zone,, Shulinzhao Town, Dalad Banner,, Ordos City, Inner Mongolia Autonomous Region
Showing of trademarks Trademarks
Trademark Classifications
Deosen Biochemical (Ordos) Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Deosen Biochemical (Ordos) Ltd. have?
Deosen Biochemical (Ordos) Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does Deosen Biochemical (Ordos) Ltd. file in?
Deosen Biochemical (Ordos) Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 1 (Chemicals). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.
What are Deosen Biochemical (Ordos) Ltd.'s most well-known trademarks?
Deosen Biochemical (Ordos) Ltd.'s registered trademark portfolio includes well-known marks such as DEOSEN, ZIBOGEL, and ZIBOZAN. These are among 3 currently registered trademarks in the portfolio.
What is Deosen Biochemical (Ordos) Ltd.'s trademark registration success rate?
Deosen Biochemical (Ordos) Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.